Jump to content

A Neuroscience Research Summit


Recommended Posts

Due to overwhelming interest you will now have the ability to watch and participate in the Summit remotely! The Summit will be VideoCast live to the public on March 22-23, 2016. Sign-up below for the live NIH VideoCast of the Summit. Information on how to access the VideoCast will be provided in your confirmation email. 

 

http://apps1.seiservices.com/nih/mj/2016/VideoCast.aspx

Link to comment
Share on other sites

  • 3 weeks later...

http://apps1.seiservices.com/nih/mj/2016/Agenda.aspx

 

 

Today's agenda. 

 

Day 2: March 23, 2016 9:00 – 9:15 a.m. Welcome and NIH Director Remarks

Nora D. Volkow, M.D., Director
NIDA

Francis S. Collins, M.D., Ph.D., Director
NIH
  9:15 – 9:45 a.m. Psychomotor Performance and Detection
Moderator:
Steve Gust, Ph.D.
NIDA

Effects of Cannabis on Human Psychomotor Performance
Marilyn Huestis, Ph.D. - BIO
University of Maryland School of Medicine
  9:45 – 11:45 a.m. Therapeutic Potential: Pain and PTSD/Anxiety

Co-Moderators:
John Williamson, Ph.D.
NCCIH

Susan Borja, Ph.D.
National Institute of Mental Health (NIMH)

Speakers:
Harnessing the Therapeutic Potential of the Endocannabinoid Signaling System to Suppress Pain
Andrea G. Hohmann, Ph.D. - BIO
Indiana University

The Therapeutic Potential of Cannabis in the Treatment of Neuropathic Pain
Barth Wilsey, M.D. - BIO
University of California, San Diego

Cannabinoids and the Processing of Fear and Anxiety: Preclinical Studies
Cecilia Hillard, Ph.D. - BIO
Medical College of Wisconsin

What is the Therapeutic Potential of Cannabis in PTSD & Anxiety Disorder Treatment?: Evidence from Human Studies
Christine Rabinak, Ph.D. - BIO
Wayne State University
  11:45 – 1:00 p.m. Scientific Poster Session
Lunch on Your Own
 
1:00 – 1:15 p.m. Summit Host Remarks

Bruce Cuthbert, Ph.D., Acting Director
NIMH

Josephine P. Briggs, M.D., Director
NCCIH
  1:15 – 3:15 p.m. Policy Research: Challenges and Future Directions

Co-Moderators:
Susan Weiss, Ph.D.
NIDA

Michael Hilton, Ph.D.
NIAAA

Speakers:
A Cannabis Research Agenda for Policy Design: What Do We Need to Know?
Mark Kleiman, Ph.D., M.P.P. - BIO
NYU Marron Institute of Urban Management
BOTEC Analysis Corporation

The Effects of Liberalizing Marijuana Policies on Use & Harms: Why Research Has Not Told Us Much
Rosalie Liccardo Pacula, Ph.D. - BIO
RAND Corporation

Regulating Retail Marijuana: Lessons Learned from Tobacco Control
Stanton Glantz, Ph.D. - BIO
University of California, San Francisco

Policy Surveillance Resources
Rosalie Liccardo Pacula, Ph.D. - BIO
RAND Corporation

Recreational Use of Cannabis to be Included in Alcohol Policy Information System
Michael Hilton, Ph.D.
NIAAA
  3:15 – 4:00 p.m. Concluding Remarks

Robert M. Califf, M.D., Commissioner of Food and Drugs
U.S. Food and Drug Administration

Nora D. Volkow, M.D., Director
NIDA
  4:00 p.m. Adjournment
Link to comment
Share on other sites

 

 

The meeting is being sponsored by several NIH Institutes and Centers:

 

the National Institute on Drug Abuse (NIDA);

the National Institute on Alcohol Abuse and Alcoholism (NIAAA);

the National Center for Complementary and Integrative Health (NCCIH);

the National Institute of Mental Health (NIMH);

the National Institute of Neurological Disorders and Stroke (NINDS).

Link to comment
Share on other sites

it looks like what they are aiming for is trying to find out how cannabis modifies the cb1/cb2 and then find a chemical that does the same thing "without getting you high".

 

except every time they develop a drug that plays with the ECS, it causes terrible depression / suicidal thoughts.

 

https://en.wikipedia.org/wiki/Rimonabant#Negative_side_effects

Link to comment
Share on other sites

another speaker just said marijuana smoking and vaping causes heart disease.

 

so there you go. quality science from nida and the nih.

 

now hes on there saying e-ciggs cause people to keep smoking ciggs.

 

heres a question, how many different groups are going after e-cigs right now?

 

big tobbacco going full force against e-cigs huh?

Link to comment
Share on other sites

I listened to a speaker discuss epilepsy when I initially posted the link yesterday and found it quite informative and thought provoking. He was discussing physiological and pharmacological mechanisms. That's the only portion I've listened to. I'll listen to more over the next few days, assuming it's available. Hopefully there's more like his presentation. 

 

The general position of the NIH seems to be somewhat expected, just have to look past that to get to the substance.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
 Share



×
×
  • Create New...